Retraction: Synthesis of bioactive yttrium-metal–organic framework as efficient nanocatalyst in synthesis of novel pyrazolopyranopyrimidine derivatives and evaluation of anticancer activity
Frontiers Editorial OfficeA Retraction of the Original Research Article
Synthesis of bioactive yttrium-metal–organic framework as efficient nanocatalyst in synthesis of novel pyrazolopyranopyrimidine derivatives and evaluation of anticancer activity
by Saleh RO, Achmad H, Daminov BT, Kzar HH, Mahdi AB, Hammid AT, Abid MK, Opulencia MJC, Mustafa YF and Sharma H (2022). Front. Chem. 10:928047. doi: 10.3389/fchem.2022.928047
The journal retracts the 2022 article cited above.
Following publication, concerns were raised regarding the contributions of the authors of the article. Our investigation, conducted in accordance with Frontiers policies, confirmed a serious breach of our authorship policies and of publication ethics; the article is therefore retracted.
This retraction was approved by the Chief Editors of Frontiers in Chemistry and the Chief Executive Editor of Frontiers. The authors have not responded to correspondence regarding this retraction.
Citation: Frontiers Editorial Office (2023) Retraction: Synthesis of bioactive yttrium-metal–organic framework as efficient nanocatalyst in synthesis of novel pyrazolopyranopyrimidine derivatives and evaluation of anticancer activity. Front. Chem. 11:1285225. doi: 10.3389/fchem.2023.1285225
Received: 29 August 2023; Accepted: 29 August 2023;
Published: 04 September 2023.
Approved by:
John D. Wade, University of Melbourne, AustraliaCopyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org